Immunovant (IMVT) Earnings Date, Estimates & Call Transcripts $30.51 +1.23 (+4.20%) (As of 10/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 6) -$0.60 Missed By -$0.07 Consensus EPS (Aug. 6) -$0.53 Conference Call TranscriptConference Call AudioEarnings Press Release Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIMVT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMVT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… Immunovant Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.48)($0.42)($0.45)Q2 20245($0.49)($0.41)($0.45)Q3 20244($0.55)($0.45)($0.49)Q4 20244($0.46)($0.37)($0.43)FY 202416($1.98)($1.65)($1.82)Q1 20253($0.57)($0.41)($0.50)Q2 20254($0.62)($0.54)($0.59)Q3 20254($0.64)($0.54)($0.59)Q4 20254($0.65)($0.55)($0.60)FY 202515($2.48)($2.04)($2.27)Q1 20262($0.63)($0.62)($0.63)Q2 20262($0.75)($0.64)($0.70)Q3 20262($0.68)($0.64)($0.66)Q4 20262($0.67)($0.64)($0.66)FY 20268($2.73)($2.54)($2.64)Q1 20271($0.55)($0.55)($0.55)Q2 20271($0.61)($0.61)($0.61)IMVT Earnings Date and InformationImmunovant last issued its earnings data on August 6th, 2024. The reported ($0.60) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.07. Immunovant has generated ($1.90) earnings per share over the last year (($1.90) diluted earnings per share). Earnings for Immunovant are expected to decrease in the coming year, from ($2.43) to ($2.69) per share. Immunovant has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.Read More Immunovant Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/6/2024Q1 2025($0.53)($0.60)($0.07)($0.60)-- 5/29/2024Q4 2024($0.44)($0.52)($0.08)($0.52)-- 2/12/2024Q4 2023($0.43)($0.36)+$0.07($0.36)--11/9/2023Q2 2024($0.45)($0.45)-($0.45)-- 8/10/2023Q1 2024($0.44)($0.47)($0.03)($0.37)-- 5/22/2023Q1 2023($0.41)($0.46)($0.05)($0.46)-- Time to pull back the curtain for you (Ad)Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman2/3/2023Q3 2023($0.41)($0.49)($0.08)($0.49)-- 11/4/2022Q2 2023($0.41)($0.41)-($0.41)-- 8/5/2022Q1 2023($0.40)($0.35)+$0.05($0.35)-- 6/8/2022Q4 2022($0.38)($0.41)($0.03)($0.41)-- 2/4/2022Q3 2022($0.34)($0.36)($0.02)($0.36)-- 11/5/2021Q3 2021($0.26)($0.35)($0.09)($0.35)-- 8/9/2021Q2 2021($0.31)($0.31)-($0.31)-- 5/31/2021Q1 2021($0.33)($0.29)+$0.04($0.29)-- 2/16/2021Q4 2020($0.25)($0.32)($0.07)($0.32)-- 11/12/2020Q3 2020($0.31)($0.25)+$0.06($0.25)-- 8/12/2020Q2 2020($0.33)($0.38)($0.05)($0.38)-- 6/29/2020Q1 2020($0.41)($0.38)+$0.03($0.38)--2/14/2020Q3 2020($0.25)($0.28)($0.03)($0.28)-- Immunovant Earnings - Frequently Asked Questions When is Immunovant's earnings date? Immunovant has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on IMVT's earnings history. Did Immunovant beat their earnings estimates last quarter? In the previous quarter, Immunovant (NASDAQ:IMVT) missed the analysts' consensus estimate of ($0.53) by $0.07 with a reported earnings per share (EPS) of ($0.60). Learn more on analysts' earnings estimate vs. IMVT's actual earnings. How can I listen to Immunovant's earnings conference call? The conference call for Immunovant's latest earnings report can be listened to online. Listen to Conference Call How can I read Immunovant's conference call transcript? The conference call transcript for Immunovant's latest earnings report can be read online. Read Transcript How much profit does Immunovant generate each year? Immunovant (NASDAQ:IMVT) has a recorded net income of -$259.34 million. IMVT has generated -$1.90 earnings per share over the last four quarters. What is Immunovant's EPS forecast for next year? Immunovant's earnings are expected to decrease from ($2.43) per share to ($2.69) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MultiPlan Earnings Utz Brands Earnings Advantage Solutions Earnings Hyliion Earnings Genmab A/S Earnings Viatris Earnings Dr. Reddy's Laboratories Earnings Vaxcyte Earnings Sarepta Therapeutics Earnings Catalent Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:IMVT) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredAI expert reveals new Nvidia predictionEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Immunovant, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.